Toggle Side Panel

About EAS
Society & Governance
Publications
Education
Collaborations
Outreach
Academy
FAQ
Become a member

Search for:

About EAS
Society & Governance
Publications
Education
Collaborations
Outreach
Academy
FAQ
Become a member

EAS Advanced Course in Rare Lipid Disorders Croatia

Tania Börjesson February 4, 2020

February 18, 2025, Zagreb, Croatia

RLD Evaluation form Croatia 2025

Newsletter

We sincerely appreciate your attendance at the Rare Lipid Disorder Course and your engagement throughout.

Your feedback is invaluable to us as we strive to improve our course offerings. We kindly ask you to take a few minutes to answer five brief questions.

Thank you for your time and support!

Please respond on a scale from 1 to 5, where 5 indicates the statement fits best, and 1 indicates it fits least.

1. On a scale of 1 to 5, how effectively can you apply what you learned to enhance patient care in your practice?

1

2

3

4

5

2. On a scale of 1 to 5, how significant were the insights you gained in impacting your approach to patient management?

1

2

3

4

5

3. On a scale of 1 to 5, how confident are you in implementing strategies from this course to improve your professional development?

1

2

3

4

5

4. On a scale of 1 to 5, how helpful were the discussions and networking in fostering collaboration?

1

2

3

4

5

5. What aspects of the course did you find particularly beneficial, and is there anything you feel was missing or could be improved? (Please share your comments below.)

Categories: Uncategorized

Recent Posts

AtheroTalk: Zanfina Ademi
Protected: EAS Young Fellows Programme Survey
Congratulations to Honorary Member Professor Albert Wiegman!
EAS Consensus Statement: FH in children and adolescents
Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund
AtheroTalk: Raul Santos
AtheroTalk: Pablo Corral

European Atherosclerosis Society
Första Långgatan 4A
413 03 Göteborg
Sweden

Phone: +46 (0) 31 760 24 27

Organisation number: 802418-0427

Send us a message

© 2026 - European Atherosclerosis Society - Privacy policy - Cookie policy - Cookie settings

Cookies

We use cookies. If you think that's OK, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings".

Settings Accept all

Cookies

Choose what kind of cookies to accept. Your choice will be saved for one year. You can change your settings from our Cookie Policy page.

Necessary
These cookies are not optional. They are needed for the website to function.
Statistics
In order for us to improve the website's functionality and structure, based on how the website is used.
Experience and analytics
If you refuse these cookies, some functionality, like the ability to view videos, will disappear from the website.
Marketing
By sharing your interests and behaviour as you visit our site, you increase the chance of seeing personalised content and offers.

Save Accept all

Report

There was a problem reporting this post.

Offensive Contains abusive or derogatory content

Inappropriate Contains mature or sensitive content

Misinformation Contains misleading or false information

Suspicious Contains spam, fake content or potential malware

Harassment Harassment or bullying behavior

Other

Report note

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

See blocked member's posts
Mention this member in posts
Invite this member to groups
Message this member
Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .